By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech Announces Filing Of 2015 "Document de Référence" And 2015 Annual Report On Form 20-F 4/29/2016 9:33:22 AM
DBV Tech To Attend Upcoming Investor Conferences 4/28/2016 8:23:21 AM
DBV Tech Announces Publication Of Experimental Data On Targeted Regulatory T Cell Induction During Epicutaneous Immunotherapy 4/12/2016 8:07:12 AM
DBV Tech Reports Full Year 2015 Financial Results 4/7/2016 10:20:18 AM
DBV Tech Announces Presentation From National Institute of Allergy And Infectious Diseases (NIAID)-Sponsored CoFAR6 Phase II Trial Reaffirming Viaskin Peanut Safety And Efficacy 3/7/2016 1:03:43 PM
DBV Tech Release: Additional Phase IIb Trial Results With Viaskin Peanut Presented At The 2016 AAAAI Meeting Continue To Support Treatment Safety, Efficacy And Compliance 3/7/2016 11:19:16 AM
DBV Tech Announces Publication Of Phase Ib Trial Results In The Journal Of Allergy And Clinical Immunology (JACI) Supporting Safety And Tolerability Of Viaskin Peanut 2/26/2016 9:17:09 AM
DBV Tech To Present New Data At The 2016 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting 2/10/2016 10:11:56 AM
DBV Tech Proudly Welcomes Edward Jordan As Senior Vice President Commercial Operations North America 1/26/2016 9:16:07 AM
DBV Tech Announces 2016 Financial Calendar 1/8/2016 10:28:53 AM